Patent

Publications

, Patent Progress
Guest Post: Is Big Tech FRANDly to Competition?
Charles Duan

On Tuesday, Apple released a new policy on its website relating to the obscure topic of “FRAND” licensing of patents. That’s an especially obscure corner of the already-obscure area of patent…

Clinic Works w/R Street Institute on PTO Comment re: AI Inventions
Charles Duan

From Harvard Law School Cyberlaw Clinic:

The Cyberlaw Clinic recently submitted a comment in response to a request from the United States Patent and Trademark Office about the patentability of…

, Harvard Law School
Clinic Contributes to SCOTUS Patent Brief Re: Pharma Prices and Access to Medical Treatments
Charles Duan

From Harvard Law School:

The Clinic collaborated with the R Street Institute, a nonprofit, nonpartisan, public policy research organization, on the brief. The case presents two questions relating…

, Bloomberg Law
Patent Challenges Muddled After Judges’ Legality Upended
Charles Duan

From Bloomberg Law:

“There are potentially dozens of decisions that will need to be redone, which will cost the USPTO and patent attorneys a lot of time and money,” Charles Duan, a patent…

, Bloomberg Law
Merck’s Patent Loss to Gilead May Have Big Impact on Drugmakers
Charles Duan

From Bloomberg Law:

The precedential Oct. 30 ruling by the U.S. Court of Appeals for the Federal Circuit suggests those patents must be written more narrowly, and it potentially exposes existing…

, Patentlyo
Georgia v. Public Resource: Twenty-five centuries of history reject the foundation of Petitioners’ case
Charles Duan

From Patentlyo:

Briefing in the case is ongoing, but I want to highlight the most interesting brief filed so far — the history-focused amicus filed by Charles Duan on behalf of R Street,…

, Patent Progress
Injunctions, National Security, and Non-U.S. Patent Holders
Charles Duan

From Patent Progress:

As we talk about SEPs and their potential national security impacts—the topic of an event on Tuesday, Oct. 15 in Washington, DC—and about patent policy more broadly,…

, Cornell Law School
Peter v. NantKwest, Inc.
Charles Duan

From Cornell Law School:

The R Street Institute (the “Institute”), arguing in support of the PTO, claims that patent applicants can appeal rejected applications through administrative…

, Law360
USPTO’s Battle For Attorney Fees, Explained
Charles Duan

From Law360:

Conservative think tank the R Street Institute, which argued that many of the benefits of a de novo appeal are still available to patent applicants via administrative procedures at…

To Fee or Not to Fee: Supreme Court to Consider Attorneys’ Fees in Patent Disputes
Charles Duan

From Congressional Research Service:

The R Street Institute (R Street), the sole amicus supporting the PTO, does not agree that NantKwest raises court-access issues. Instead, R Street contends…